Unique ID issued by UMIN | UMIN000028469 |
---|---|
Receipt number | R000032591 |
Scientific Title | clinical study of Robot-Assisted Radical Cystectomy for invasive bladder cancer |
Date of disclosure of the study information | 2017/08/01 |
Last modified on | 2019/08/14 15:48:34 |
clinical study of Robot-Assisted Radical Cystectomy for invasive bladder cancer
RARC for bladder cancer
clinical study of Robot-Assisted Radical Cystectomy for invasive bladder cancer
RARC for bladder cancer
Japan |
invasive bladder cancer
Urology |
Malignancy
NO
Consider the safety and efficacy for robot-assisted radical cystectomy using daVinci Si System.
Safety
Intra and and postoperative complications and their contents
operation time, duration for anesthesia, a, bleeding, postoperative use for pain medication, postoperative hospitalization period, histopathological findings
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Maneuver |
Radical cystectomy performed with daVinci Si system,
20 | years-old | <= |
Not applicable |
Male and Female
Invasive bladder cancer cT1-2N0M0
,who obtained written informed consent
1 The patient seems to be difficult for robot-assisted surgery due to previous surgery.
2. The patient with multiple cancers (cancer combined cancer and disease-free period within five years of different multiple cancer).
3. patients with impossible discontinuation of anticoagulants.
4. patients requiring blood transfusion due to anemia or bleeding.
5. morbid obesity (bimi35 or higher)
6. renal transplant history.
7. dialysis patients.
8. pregnant women or pregnant or lactating women
9. patients with a mental illness or psychiatric symptoms.
10. patients who is difficult for surgical treatment because of serious complications (angina pectoris, myocardial infarction, serious arrhythmias, uncontrolled diabetes, malignant hypertension, etc.
11. patients who have renal dysfunction (serum creatinine levels 1.5mg/dl or more), liver dysfunction (AST, ALT 100IU/l or more).
12. patients with bacterial infections requiring treatments.
13. patients with interstitial pneumonitis and pulmonary fibrosis.
14. patients with severe drug hypersensitivity, drug allergies.
15. minors
16. patients seemed unfit for other reasons.
3
1st name | Tomoaki |
Middle name | |
Last name | Miyagawa |
Jichi Medical University, Satiama Medical Center
Department of Urology
330-8503
1-847 Amanuma-cho, Omiya-ku, Saitama city, Saitama, Japan
048-647-2111
sh2-miya@jichi.ac.jp
1st name | Tomoaki |
Middle name | |
Last name | Miyagawa |
Jichi Medical University, Satiama Medical Center
Department of Urology
3308503
1-847 Amanuma-cho, Omiya-ku, Saitama city, Saitama, Japan
048-647-2111
sh2-miya@jichi.ac.jp
Jichi Medical University, Satiama Medical Center
Department of Urology
Jichi Medical University, Satiama Medical Center
Department of Urology
Self funding
Jichi Medical University, Satiama Medical Center
1-847 Amanuma-cho, Omiya-ku, Saitama city, Saitama, Japan
048-647-2111
sh2-miya@jichi.ac.jp
NO
2017 | Year | 08 | Month | 01 | Day |
Partially published
3
All three patients were male
Age 64-77
Invasive bladder cancer
Urinary diversion is 2 cases of ileal conduit, 1 case of cutaneostomy
Surgery time 363-507 minutes
Console time 215-267 minutes
Blood loss 60-500ml
No postoperative complications
Discharged 10-14 days after surgery.
2019 | Year | 08 | Month | 14 | Day |
2019 | Year | 02 | Month | 07 | Day |
Enrolling by invitation
2017 | Year | 06 | Month | 01 | Day |
2017 | Year | 08 | Month | 01 | Day |
2017 | Year | 07 | Month | 31 | Day |
2019 | Year | 08 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032591